重组小鼠CD33(Siglec-3)

特别提示：包括重组小鼠CD33(Siglec-3)在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：重组小鼠CD33(Siglec-3)
英文名称：Recombinant Mouse Sialic Acid Binding Ig-like Lectin 3

产品货号：重组小鼠CD33(Siglec-3)
产品规格：10μg|50μg|500μg|1mg

本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Asp18-Glu240在C端含有His标签。

CD33/Siglec-3质量控制：＞95%(还原性SDS-PAGE)

CD33/Siglec-3制剂：冻干品

CD33/Siglec-3保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

CD33/Siglec-3复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于CD33/Siglec-3：
Mouse myeloid cell surface antigen CD33(CD33) is a member of the immunoglobulin superfamily and SIGLEC (sialic acid binding Ig-like lectin) family. CD33 contains one Ig-like C2-type domain and one Ig-like V-type domain. CD33 is a putative adhesion molecule of myelomonocytic-derived cells that mediates sialic-acid dependent binding to cells. CD33 preferentially binds to alpha-2,6-linked sialic acid. The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface. In the immune response, CD33 may act as an inhibitory receptor upon ligand induced tyrosine phosphorylation by recruiting cytoplasmic phosphatase(s) via their SH2 domain(s) that block signal transduction through dephosphorylation of signaling molecules. CD33 induces apoptosis in acute myeloid leukemia. CD33 is becoming increasingly important as a target of antibody-mediated therapy in acute myeloid leukaemia (AML).

除了重组小鼠CD33(Siglec-3),，我公司还供应以下相关产品：
 

货号	名称	规格
JN0214	重组人SCF(干细胞因子)	10μg|50μg|500μg|1mg
JN0222	重组人NT3(神经营养素3)	10μg|50μg|500μg|1mg
JN0341	重组小鼠白介素IL-1α(白细胞介素1α)	10μg|50μg|500μg|1mg
JN0659	重组人γ-氨基丁*(代"酸")受体结合蛋白样1(GABARAPL1)	10μg|50μg|500μg|1mg
JN0683	重组人泛素结合酶E2-S(UBE2S)	10μg|50μg|500μg|1mg
JN0758	重组人GNRH2(促性腺激素释放素2)	10μg|50μg|500μg|1mg
JN1292	重组人TAG-1(瞬变轴突蛋白1)(短暂表达轴突糖蛋白1)(CNTN2)	10μg|50μg|500μg|1mg
JN1310	重组家犬SPP1	10μg|50μg|500μg|1mg
JN1462	重组人PD-L1(B7-H1)	10μg|50μg|500μg|1mg
JN1662	重组人PPP1R14A	10μg|50μg|500μg|1mg
JN1858	重组人CD160	10μg|50μg|500μg|1mg
ZN1787	小鼠MMP8重组蛋白	100ng